Gabapentin NDC 69434-043

NDC codes

FDA NDC Directory

Product NDC (as listed)69434-043Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69434-0043Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69434-043-03	69434004303	500 CAPSULE in 1 BOTTLE (69434-043-03)Marketed from Jul 1, 2026
69434-043-04	69434004304	100 CAPSULE in 1 BOTTLE (69434-043-04)Marketed from Jul 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zhejiang Yongtai Pharmaceutical Co., Ltd
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213603
Marketing start: Jul 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 69434-043_50180dbb-2297-4ddd-bf6a-a2084827f1cfSPL ID 50180dbb-2297-4ddd-bf6a-a2084827f1cfSPL set ID f1eda6cc-d9b2-4df4-a09b-20eebded760fRxCUI 310430, 310431, 310432UNII 6CW7F3G59XUPC 0369434042049, 0369434043046, 0369434044043

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469434004303 followed by a unit qualifier and the quantity

Package 69434-0043-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 25, 2026.

Indications (excerpt from the label)

Gabapentin is indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin is indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 213603

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213603
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Direct_Rx	72189-384
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2381
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Zhejiang Yongtai Pharmaceutical Co., Ltd	69434-042
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Zhejiang Yongtai Pharmaceutical Co., Ltd	69434-044
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-2478